ArticleCureus2026
A Short Case Series of Common Variable Immunodeficiency From a Tertiary Care Hospital in South India.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Common variable immunodeficiency (CVID) is the most prevalent clinically significant primary antibody deficiency, characterised by markedly reduced serum immunoglobulin levels and impaired vaccine responses. It typically presents with recurrent sinopulmonary infections and may be associated with autoimmune phenomena, granulomatous disease, and malignancy. Despite its clinical impact, CVID remains substantially underdiagnosed, with a considerable delay between symptom onset and diagnosis. We present three cases managed at a tertiary care centre in Kerala, India, illustrating the diverse clinical presentations of CVID across different age groups. The first was a 32-year-old woman with long-standing bilateral bronchiectasis, prior lung surgery, and recurrent infections attributed to severely reduced IgG and IgA levels. The second was a 14-year-old girl with recurrent respiratory and ear infections since childhood, bronchiectasis, clubbing, and lymphadenopathy, in whom marked hypogammaglobulinemia supported the diagnosis of CVID after exclusion of secondary causes. The third was a 50-year-old man presenting with consolidation, maxillary sinusitis, and significant weight loss, in whom pan-hypogammaglobulinaemia involving IgG, IgA, and IgM supported the diagnosis. These cases underscore the importance of maintaining a high index of suspicion for primary immunodeficiency in patients across all age groups presenting with recurrent sinopulmonary infections. Early immunological evaluation, including serum immunoglobulin quantification, is essential for timely diagnosis, and immunoglobulin replacement therapy remains the cornerstone of management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.